Japanese guidelines for allergic conjunctival diseases 2017
-
- Takamura Etsuko
- Department of Ophthalmology, Tokyo Women's Medical University, School of Medicine
-
- Uchio Eiichi
- Department of Ophthalmology, Fukuoka University, School of Medicine
-
- Ebihara Nobuyuki
- Department of Ophthalmology, Juntendo University Urayasu Hospital
-
- Ohno Shigeaki
- Department of Ophthalmology, Hokkaido University Graduate School of Medicine
-
- Ohashi Yuichi
- Department of Ophthalmology, Ehime University School of Medicine
-
- Okamoto Shigeki
- Okamoto Eye Clinic
-
- Kumagai Naoki
- Kumagai Eye Clinic
-
- Satake Yoshiyuki
- Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital
-
- Shoji Jun
- Division of Ophthalmology, Department of Visual Sciences, Nihon University, School of Medicine
-
- Nakagawa Yayoi
- Nakagawa Eye Clinic
-
- Namba Kenichi
- Department of Ophthalmology, Hokkaido University Graduate School of Medicine
-
- Fukagawa Kazumi
- Ryogoku Eye Clinic Department of Ophthalmology, Keio University School of Medicine
-
- Fukushima Atsuki
- Department of Ophthalmology, Kochi Medical School
-
- Fujishima Hiroshi
- Department of Ophthalmology, Tsurumi University School of Dental Medicine
この論文をさがす
抄録
<p>The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease (Second Edition) revised in 2010. Allergic conjunctival disease is defined as “a conjunctival inflammatory disease associated with a Type I allergy accompanied by some subjective or objective symptoms.” Allergic conjunctival disease is classified into allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis. Representative subjective symptoms include ocular itching, hyperemia, and lacrimation, whereas objective symptoms include conjunctival hyperemia, swelling, folliculosis, and papillae. Patients with vernal keratoconjunctivitis, which is characterized by conjunctival proliferative changes called giant papilla accompanied by varying extents of corneal lesion, such as corneal erosion and shield ulcer, complain of foreign body sensation, ocular pain, and photophobia. In the diagnosis of allergic conjunctival diseases, it is required that type I allergic diathesis is present, along with subjective and objective symptoms accompanying allergic inflammation. The diagnosis is ensured by proving a type I allergic reaction in the conjunctiva. Given that the first-line drug for the treatment of allergic conjunctival disease is an antiallergic eye drop, a steroid eye drop will be selected in accordance with the severity. In the treatment of vernal keratoconjunctivitis, an immunosuppressive eye drop will be concomitantly used with the abovementioned drugs.</p>
収録刊行物
-
- Allergology International
-
Allergology International 66 (2), 220-229, 2017
一般社団法人日本アレルギー学会
- Tweet
キーワード
詳細情報
-
- CRID
- 1390282679608734720
-
- NII論文ID
- 130005628172
-
- ISSN
- 14401592
- 13238930
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可